BioCentury
ARTICLE | Finance

Science 37, Castor raise funds as decentralized trials gain traction

August 20, 2020 10:28 PM UTC

Science 37 and Castor each raised venture funding this week to expand their virtual trial platforms as companies increasingly turn to decentralized trials to keep studies running during the pandemic and beyond.

Decentralized trials will also help to increase racial and socioeconomic diversity in clinical trials by lowering the logistical barriers to participation (see ““Can the Vogue of Decentralized Trials Continue Beyond the Pandemic?”)...